CAMBRIDGE, Mass., Feb. 1 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. announced today that Idenix management will present a corporate overview at the upcoming 12th Annual BIO CEO & Investor Conference on Monday, February 8, 2010 at 9:30 a.m. ET at the Waldorf-Astoria Hotel in New York, NY.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix’s current focus is on the treatment of infections caused by the hepatitis C virus. For further information about Idenix, please refer to http://www.idenix.com.
Idenix Pharmaceuticals, Inc.
